Altamira Therapeutics Ltd.
Pharmaceutical Preparations · HAMILTON HM 11
High confidence (85%)
Updated Oct 18, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
Latest material event: Altamira Therapeutics Ltd. deregistered its securities (Feb 27, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Altamira Therapeutics Ltd. deregistered its securities
Feb 27, 2026
Registration withdrawn
- SEC EDGAR — “15-12G 1 eaf1512g-1512g_altamira.htm FORM 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36582 Altamira Therapeutics Ltd. (Exact name of registrant as specified in its charter) Clarendon House 2 Church Street Hamilton HM11 Bermuda +1 (441) 295 59 50 (Address, including zip code, and telephone number, including…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker CYTOF on OTC.
- SEC CIK
- 0001601936
- Website
- —
- —
- Headquarters
- HAMILTON HM 11
- Also known as
- Auris Medical AG, Auris Medical Holding Ltd.
- Legal entities
- Altamira Therapeutics Ltd.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Altamira Therapeutics Ltd. — Pharmaceutical Preparations (SIC 2834) — HAMILTON HM 11, Bermuda
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
15-12G 1 eaf1512g-1512g_altamira.htm FORM 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-36582 Altamira Therapeutics Ltd. (Exact name of registrant as specified in its charter) Clarendon House 2 Church Street Hamilton HM11 Bermuda +1 (441) 295 59 50 (Address, including zip code, and telephone number, including…
View source record
Status history
Every derived status, with the rule that produced it.
- NO_LONGER_LISTED → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:31 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:14 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:05 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:14 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.